Unravelling True buRden of atrIal fibrillation across then whole spectrUm; froM asymPtomatic pHase to critical disease.

Unravelling True buRden of atrIal fibrillation across then whole spectrUm; froM asymPtomatic pHase to critical disease. - TRIUMPH

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56639

Enrollment

2000

Registered

2024-03-06

Start date

2024-09-18

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants of the Rotterdam Study

Exclusion criteria

Exclusion criteria: Participants with a pacemaker or other stimulator device

Design outcomes

Primary

Measure	Time frame
Presence of atrial fibrillation and AF burden score	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results